Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003660-e1003660
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Katherine Owens, Shadisadat Esmaeili, Joshua T. Schiffer
JCI Insight (2024) Vol. 9, Iss. 9
Open Access | Times Cited: 11
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 5, pp. 591-603
Open Access | Times Cited: 15
Defining the Critical Requisites for Accurate Simulation of SARS‐CoV‐2 Viral Dynamics: Patient Characteristics and Data Collection Protocol
H.C. Chua, Ananya Singh, Yuqian Wang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Age- and vaccination status-dependent isolation guidelines based on simulation of SARS-CoV-2 Delta cases in Singapore
Keisuke Ejima, Marco Ajelli, Ananya Singh, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Designing isolation guidelines for COVID-19 patients with rapid antigen tests
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies
James A Watson, Stephen M. Kissler, Nicholas Day, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 7
Open Access | Times Cited: 23
The kinetics of SARS-CoV-2 infection based on a human challenge study
Sarafa A. Iyaniwura, Ruy M. Ribeiro, Carolin Zitzmann, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 46
Open Access | Times Cited: 4
Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets
Naveen K. Vaidya, Angelica Bloomquist, Alan S. Perelson
Viruses (2021) Vol. 13, Iss. 8, pp. 1635-1635
Open Access | Times Cited: 27
Comparing antiviral strategies against COVID-19 via multiscale within-host modelling
Farzad Fatehi, Richard J. Bingham, Eric C. Dykeman, et al.
Royal Society Open Science (2021) Vol. 8, Iss. 8, pp. 210082-210082
Open Access | Times Cited: 25
An age-structured model of hepatitis B viral infection highlights the potential of different therapeutic strategies
Farzad Fatehi, Richard J. Bingham, Peter G. Stockley, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection
Kwang Su Kim, Shoya Iwanami, Takafumi Oda, et al.
Life Science Alliance (2021) Vol. 4, Iss. 10, pp. e202101049-e202101049
Open Access | Times Cited: 21
Precision epidemiology at the nexus of mathematics and nanotechnology: Unraveling the dance of viral dynamics
Alaa A. A. Aljabali, Mohammad A. Obeid, Mohamed El‐Tanani, et al.
Gene (2024) Vol. 905, pp. 148174-148174
Closed Access | Times Cited: 2
Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study
Keisuke Ejima, Kwang Su Kim, Ana I. Bento, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution
Junya Sunagawa, Hyeongki Park, Kwang Su Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review
Yang Li, Lipeng Niu
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Mathematical model explains differences in Omicron and Delta SARS-CoV-2 dynamics in Caco-2 and Calu-3 cells
В. М. Староверов, Alexei Galatenko, E. N. Knyazev, et al.
PeerJ (2024) Vol. 12, pp. e16964-e16964
Open Access | Times Cited: 1
Stem cell therapy for COVID-19 pneumonia
Maziar Malekzadeh Kebria, Peiman Brouki Milan, Noshad Peyravian, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 8
Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells
В. М. Староверов, Stepan Nersisyan, Alexei Galatenko, et al.
PeerJ (2023) Vol. 11, pp. e14828-e14828
Open Access | Times Cited: 4
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19
Taiga Miyazaki, Naoki Hosogaya, Yuri Fukushige, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 4
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response
Veronika I. Zarnitsyna, Juliano F. Gianlupi, Amit Hagar, et al.
Current Opinion in Virology (2021) Vol. 50, pp. 103-109
Open Access | Times Cited: 10
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Katherine Owens, Shadisadat Esmaeili, Joshua T. Schiffer
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study
William S. Hart, Hyeongki Park, Yong Dam Jeong, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 41
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top